MSH2 and Familial prostate cancer: Genomic events leading to a mismatch repair (MMR) deficiency and microsatellite instability (MSI) have been reported in 3.1% of prostate cancer cases, mostly affecting MSH2 [17], and associated with increased risk of prostate cancer and higher mutational tumor burden [18].